Brazilian pharmaceutical manufacturer with 106+ medicines across generic, supplement, and OTC segments
Globo Pharma operates a 41,000 m² manufacturing facility in Minas Gerais producing 106 drugs across 424+ presentations (generics, supplements, phytotherapeutics, OTC). The tech stack is heavy on legacy ERP (SAP, Oracle Primavera) and manufacturing floor systems (SCADA, WMS, HPLC), with no modern adoption signals—typical of a 70-year-old pharma incumbent focused on operational continuity. Hiring accelerates in manufacturing and logistics (16 roles in 30 days), aligned to active expansion projects and internal friction around inventory, freight, and unplanned downtime.
Globo Pharma is a privately held Brazilian pharmaceutical manufacturer founded in 1954, headquartered in São José da Lapa in the Belo Horizonte metropolitan area. The company distributes generic medications, branded pharmaceuticals, nutritional supplements, and health products across Brazil, leveraging over 500 employees and an established national distribution network. Their portfolio spans prescription and non-prescription categories, with stated emphasis on product safety, quality infrastructure, and cost-accessible healthcare delivery. Operations span manufacturing, logistics, quality, and distribution functions at a 501–1,000-person scale.
106 medications across 424+ presentations: generics, similars, phytotherapeutics, OTC, and nutritional supplements. Categories include prescription medicines, supplements, nutraceuticals, and cosmetics.
Headquarters in São José da Lapa, Minas Gerais, Brazil. Operating facility spans 41,000 m² in the Belo Horizonte metropolitan region.
Other companies in the same industry, closest in size